Literature DB >> 16298551

The etiology of sepsis: turned inside out.

Gregory J Brunn1, Jeffrey L Platt.   

Abstract

The sepsis syndrome is thought to occur when microbial products activate Toll-like receptors stimulating widespread inflammation, in turn causing organ failure, shock and death. However, recent discoveries reveal that: (i) not only microbial substances but also endogenous molecules can trigger Toll-like receptors; (ii) Toll-like receptor-4, the endotoxin receptor, is constitutively suppressed; and (iii) the first step in sepsis could be the release of Toll-like receptor-4 from suppression. These discoveries suggest that endotoxin might not always initiate the sepsis syndrome and they explain why anti-endotoxin therapies fail. The discoveries also suggest new therapeutic targets - endogenous agonists and Toll-like receptor regulators - for treatment of sepsis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16298551     DOI: 10.1016/j.molmed.2005.11.002

Source DB:  PubMed          Journal:  Trends Mol Med        ISSN: 1471-4914            Impact factor:   11.951


  8 in total

1.  Sepsis under siege: a new understanding of sepsis might lead to the development of therapies to treat septic shock.

Authors:  Philip Hunter
Journal:  EMBO Rep       Date:  2006-07       Impact factor: 8.807

2.  Surviving lethal septic shock without fluid resuscitation in a rodent model.

Authors:  Yongqing Li; Baoling Liu; Eugene Y Fukudome; Ashley R Kochanek; Robert A Finkelstein; Wei Chong; Guang Jin; Jennifer Lu; Marc A deMoya; George C Velmahos; Hasan B Alam
Journal:  Surgery       Date:  2010-06-19       Impact factor: 3.982

3.  When apoptosis meets autophagy: deciding cell fate after trauma and sepsis.

Authors:  Ya-Ching Hsieh; Mohammad Athar; Irshad H Chaudry
Journal:  Trends Mol Med       Date:  2009-02-21       Impact factor: 11.951

Review 4.  Heparan Sulfate Proteoglycan Metabolism and the Fate of Grafted Tissues.

Authors:  Jeffrey L Platt; Lucile E Wrenshall; Geoffrey B Johnson; Marilia Cascalho
Journal:  Adv Exp Med Biol       Date:  2015       Impact factor: 2.622

5.  Lipopolysaccharide inhibits the channel activity of the P2X7 receptor.

Authors:  Elias Leiva-Salcedo; Claudio Coddou; Felipe E Rodríguez; Antonello Penna; Ximena Lopez; Tanya Neira; Ricardo Fernández; Mónica Imarai; Miguel Rios; Jorge Escobar; Margarita Montoya; J Pablo Huidobro-Toro; Alejandro Escobar; Claudio Acuña-Castillo
Journal:  Mediators Inflamm       Date:  2011-09-14       Impact factor: 4.711

6.  Molecular mechanisms in the pathogenesis of sepsis.

Authors:  V Pop-Began; V Păunescu; V Grigorean; D Pop-Began; C Popescu
Journal:  J Med Life       Date:  2014

Review 7.  Pandemic influenza: a potential role for statins in treatment and prophylaxis.

Authors:  David S Fedson
Journal:  Clin Infect Dis       Date:  2006-06-12       Impact factor: 9.079

8.  Cytokines in the systemic inflammatory response syndrome: a review.

Authors:  U Jaffer; R G Wade; T Gourlay
Journal:  HSR Proc Intensive Care Cardiovasc Anesth       Date:  2010
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.